コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 infection compared with those born in 1988 (adjusted odds ratio 0.13 [95% CI 0.06-0.28]) and reduced
2 ences in prevalence between groups for PTSD (adjusted odds ratio 0.92, 95% CI 0.75-1.14), depression
3 particularly among very-high-risk drinkers (adjusted odds ratios 0.27 [95% CI 0.18-0.41] for reducti
4 k difference = 4.1% [95% CI, -1.4% to 9.6%]; adjusted odds ratio = 0.61 [95% CI, 0.31 to 1.21]; P = .
5 odds ratio = 0.77, P < 0.001) and Hispanic (adjusted odds ratio = 0.76, P = 0.007) patients were les
6 ustment for baseline characteristics, black (adjusted odds ratio = 0.77, P < 0.001) and Hispanic (adj
7 k difference = 1.1% [95% CI, -3.1% to 5.4%]; adjusted odds ratio = 0.78 [95% CI, 0.35 to 1.76]; P = .
10 ociated with a significant reduction in AKI (adjusted odds ratio, 0.13; 95% confidence intervals, 0.0
11 confidence intervals, 0.25-0.83; P=0.04 and adjusted odds ratio, 0.16; 95% confidence intervals, 0.1
12 ital admission compared to no NAI treatment (adjusted odds ratio, 0.24; 95% confidence interval, 0.20
16 her associated with 14-day clinical failure (adjusted odds ratio, 0.62; 95% CI, .29-1.36) nor length
17 less likely to be full professors than men (adjusted odds ratio, 0.63; 95% confidence interval, 0.43
18 AD support protection against AKI persisted (adjusted odds ratio, 0.63; 95% confidence intervals, 0.2
19 rdless of individual patient race/ethnicity (adjusted odds ratio, 0.65; 95% CI, 0.50-0.84 for intrace
20 received less intensive therapy (30% v 48%; adjusted odds ratio, 0.65; CI, 0.44 to 0.98) compared wi
21 bo (90 of 457 [19.7%] vs 130 of 473 [27.5%]; adjusted odds ratio, 0.66; 95% CI, 0.48-0.90; P = .009).
23 ative mortality decreased from 4.1% to 2.9% (adjusted odds ratio, 0.68; 95% CI, 0.58 to 0.81; P < .00
24 95% CI, 0.68-0.85; P < .001) and low-volume (adjusted odds ratio, 0.75; 95% CI, 0.60-0.92; P = .007)
25 d consistent after multivariable adjustment (adjusted odds ratio, 0.76; 95% CI, 0.58-0.98; P = .04).
26 in high-volume compared with medium-volume (adjusted odds ratio, 0.76; 95% CI, 0.68-0.85; P < .001)
27 receive placebo (145 [31.7%] vs 174 [37.6%]; adjusted odds ratio, 0.78; 95% CI, 0.59-1.02; P = .07).
28 h to preservation, the presence of diabetes (adjusted odds ratio, 0.79; 95% CI, 0.51-1.22; P = .28) a
29 studies, with lower mortality in overweight (adjusted odds ratio, 0.79; 95% confidence interval, 0.76
31 ratio, 0.98; 95% CI, 0.68-1.4) nor negative (adjusted odds ratio, 0.81; 95% CI, 0.43-1.55) fluid bala
32 as associated with lower hospital mortality (adjusted odds ratio, 0.81; 95% CI, 0.70-0.94) but did no
33 wer during nights than during days/evenings (adjusted odds ratio, 0.88 [95% CI, 0.80-0.97]; P = .007)
34 ICU utilization (high vs low: 8.7% vs 8.7%; adjusted odds ratio, 0.91; 95% CI, 0.76-1.08; intermedia
35 not different between weekends and weekdays (adjusted odds ratio, 0.92 [95% CI, 0.84-1.01]; P = .09).
36 rence to MI performance measures and MI-ERR (adjusted odds ratio, 0.94; 95% CI, 0.81-1.08, per 0.1-un
37 renal replacement therapy, neither positive (adjusted odds ratio, 0.98; 95% CI, 0.68-1.4) nor negativ
38 , status 1A listing was unchanged over time (adjusted odds ratio, 0.98; 95% confidence interval, 0.78
39 ed with the highest, had reduced odds of MI (adjusted odds ratio: 0.65; 95% confidence interval: 0.55
40 ncident sensitization to inhalant allergens (adjusted odds ratio: 0.73, 95% confidence interval: 0.55
41 days unable to work (no days unable to work adjusted odds ratio 1.02 [0.61-1.69]; p=0.95), suicide a
43 ediate (31-364 days) incarceration duration (adjusted odds ratio 1.52; 95% CI 1.19-1.95), and transit
44 nce in the past 14 days (45.1% versus 26.4%; adjusted odds ratio 1.92 [95% CI 1.19, 3.10]; p = 0.008)
45 te risk increase = 3.7% [95% CI, 1.5%-6.0%]; adjusted odds ratio = 1.15 [95% CI, 1.01-1.30]; P = .03)
46 of 421 (24.5%) assigned to receive placebo (adjusted odds ratio, 1.00; 99% confidence interval [CI],
48 sts (66 of 458 [14.4%] vs 61 of 462 [13.2%]; adjusted odds ratio, 1.11; 95% CI, 0.77-1.61; P = .58) a
49 sus 288 of 767 (37.6%) for control subjects (adjusted odds ratio, 1.17; 95% confidence interval, 0.94
50 d in 48 (11.4%) assigned to receive placebo (adjusted odds ratio, 1.18; 96% CI, 0.76 to 1.82; P=0.45)
51 (562/3335) without sibling MR (multivariable-adjusted odds ratio, 1.20; 95% confidence interval [CI],
52 ot associated with the presence of diabetes (adjusted odds ratio, 1.23; 95% CI, 0.66-2.32; P = .52).
53 tients treated by low-intensity prescribers (adjusted odds ratio, 1.30; 95% confidence interval, 1.23
54 lems (52 of 476 [10.9%] vs 40 of 481 [8.3%]; adjusted odds ratio, 1.32; 95% CI, 0.85-2.07; P = .22) w
57 ], 1.15-1.18) and incidence of C. difficile (adjusted odds ratio, 1.42; 95% CI, 1.09-1.85) without a
58 ar carcinoma vs those with ductal carcinoma (adjusted odds ratio, 1.44; 95% CI 1.06-1.95; P = .02).
59 ervices compared with the noncritical group (adjusted odds ratio, 1.46; 95% confidence interval, 1.15
60 usted proportion, 10.3%; 95% CI, 9.10-11.54; adjusted odds ratio, 1.50; 95% CI, 1.21-1.98) compared w
61 sted proportion, 13.2%; 95% CI, 11.81-14.58; adjusted odds ratio, 1.57; 95% CI, 1.25-1.96) and neurol
62 , and those with no health insurance (17.6%; adjusted odds ratio, 1.5; P<0.001) compared with white p
63 ailure, cardiogenic shock, and reinfarction (adjusted odds ratio, 1.65; 95% confidence interval, 1.18
65 risk compared with conventional ventilation (adjusted odds ratio, 1.75; 95% confidence interval, 1.04
66 y day 28 after adjustment for 16 covariates (adjusted odds ratio, 1.77; 95% CI, 1.17 to 2.68); death
67 h no more than high-school education (17.3%; adjusted odds ratio, 1.7; P=0.001), and those with no he
68 2.23; P < .001; chronic noncancer condition: adjusted odds ratio, 1.82; 95% CI, 1.69-1.97; P < .001).
69 highest decile of OOP expenditures (cancer: adjusted odds ratio, 1.86; 95% CI, 1.55-2.23; P < .001;
70 IgE sensitization to peanut at age 4 years (adjusted odds ratio, 1.88; 95% CI, 1.03-3.44) but not to
73 , including increased reliance on gait aids (adjusted odds ratio, 1.9; 95% CI, 1.4-2.6); no functiona
74 justed odds ratio: 1.16 for low versus high; adjusted odds ratio: 1.05 for intermediate vs. high volu
75 associated with a 5% increased odds of DGF (adjusted odds ratio: 1.05, 95% confidence interval [CI],
76 th those performed by high-volume operators (adjusted odds ratio: 1.16 for low versus high; adjusted
77 MSAs) on cranial magnetic resonance imaging (adjusted odds ratio, 10.3 [95% confidence interval {CI},
78 in risk of tuberculosis disease among HHCs (adjusted odds ratio, 10.53; 95% confidence interval, 3.7
79 ly and clinically significant (multivariable-adjusted odds ratio 12.5; 95% CI, 1.1-146.1, P = 0.0438)
80 r remission rate (68.2% compared with 22.2%; adjusted odds ratio=12.6) at weeks 4-6 and significantly
82 ude presentation with neurological symptoms (adjusted odds ratio, 16.0; P<0.001) and gastrointestinal
83 81), preterm labor during current pregnancy (adjusted odds ratio, 18.34; 95% CI, 4.95-67.96), vaginit
84 e beds in the highest quartile of occupancy (adjusted odds ratio, 18.9; 95% CI, 14.0-25.5; p < 0.01)
85 atus 1A listing increased 117% over 9 years (adjusted odds ratio 2.17, 95% confidence interval, 1.82-
86 8 percentage points difference, 95% CI 5-30; adjusted odds ratio 2.60, 95% CI 1.43-4.73; p=0.002).
87 ted proportion, 12.89%; 95% CI, 10.69-15.09; adjusted odds ratio, 2.06; 95% CI, 1.51-2.79) was associ
89 nsported to PCI centers (33.5% versus 14.6%; adjusted odds ratio, 2.47; 95% confidence interval, 2.08
93 3.8; P<0.001), people of other races (18.7%; adjusted odds ratio, 2.5; P<0.001), those with no more t
94 eeding was associated with higher mortality (adjusted odds ratio, 2.70; 95% CI, 2.27-3.22; P < .001)
96 increased for Ghanaian men living in Berlin (adjusted odds ratio, 2.80; 95% confidence interval, 1.76
98 2 ng/L versus <limit of detection [<3 ng/L]; adjusted odds ratio, 2.87; 95% confidence interval, 1.38
101 ound characteristics (nonmedical opioid use: adjusted odds ratio=2.62, 95% CI=1.86-3.69; opioid use d
102 th increased incident nonmedical opioid use (adjusted odds ratio=2.99, 95% CI=1.63-5.47) at wave 2; i
103 ldren who saw the movie not containing guns (adjusted odds ratio, 22.3; 95% CI, 6.0-83.4; P < .001).
104 ical outcome included cervical incompetence (adjusted odds ratio, 24.29; 95% CI, 7.48-78.81), preterm
105 ent (65%) and conservative management (97%) (adjusted odds ratio, 24.9; P<0.01, compared with surgery
106 t in the past 14 days (68 [42%] vs 31 [18%]; adjusted odds ratio 3.00 [1.76-5.13]; p<0.0001) were sig
107 (48%) households in the $2 incentive group (adjusted odds ratio 3.67, 95% CI 2.77-4.85; p<0.0001), a
108 increase in odds of incident M. genitalium (adjusted odds ratio = 3.49, 95% confidence interval: 1.8
109 ed (odds ratio, 3.00; 95% CI, 1.10-8.17) and adjusted (odds ratio, 3.26; 95% CI, 1.16- 9.16) analyses
111 ldren who saw the movie not containing guns (adjusted odds ratio, 3.0; 95% CI, 0.9-9.9; P = .07).
116 54 of 3391 [13.4%]) underwent a reoperation (adjusted odds ratio, 3.82; 95% CI, 3.19-4.58; P < .001).
117 ciated with an increased risk of early POAF (adjusted odds ratio, 3.88; 95% confidence interval, 2.89
118 SBL-E rectal carriage at hospital admission (adjusted odds ratio, 3.89; 95% confidence interval, 1.65
119 kely for black people (25.8% newly eligible; adjusted odds ratio, 3.8; P<0.001), people of other race
121 with inhaled corticosteroids at age 7 years (adjusted odds ratio, 4.01 [95% confidence interval (CI),
122 ed variability of nevus dermoscopic pattern (adjusted odds ratio, 4.24; 95% CI, 1.36-13.25; P = .01)
124 rong and independent predictor of mortality (adjusted odds ratio, 4.39; CI = 1.96-9.99; p < 0.001).
125 T2D (89 of 283 [31.4%] vs 26 of 282 [9.2%]; adjusted odds ratio, 4.6; 95% CI, 1.5-14.7) and a greate
126 -0.06]; P = 0.0348), and allergic rhinitis (adjusted odds ratio, 4.83 [95% CI, 1.58-14.78]; P = 0.00
128 ompared with non-CP-CRE bacteremic patients (adjusted odds ratio, 4.92; 95% confidence interval, 1.01
129 ge rate (13/61 [21.1%] vs. 240/2172 [11.0%], adjusted odds ratio: 4.2, 95% CI: 1.60-10.98, p = 0.004)
130 were conviction for previous violent crime (adjusted odds ratio 5.03 [95% CI 4.23-5.98]; p<0.0001),
131 I, 4.95-67.96), vaginitis or vulvovaginitis (adjusted odds ratio, 5.17; 95% CI, 2.19-12.23), and seps
132 tion index; intravenous iron use for anemia (adjusted odds ratio, 5.4 [95% confidence interval, 1.4-2
133 syndrome severe acute respiratory infection (adjusted odds ratio, 5.87; 95% CI, 4.02-8.56; p < 0.001)
134 dren undergoing PPT stopped using laxatives (adjusted odds ratio, 6.5; 95% confidence interval, 1.6-2
136 pitals in the highest quartile of occupancy (adjusted odds ratio, 7.3; 95% CI, 5.3-9.9; p < 0.01).
137 nhanced standard-of-care group (n=128 [56%]; adjusted odds ratio 9.88, 95% CI 5.55-17.57; p<0.0001).
138 ariate analysis, baseline total nevus count (adjusted odds ratio, 9.08; 95% CI, 4.0-23.7; P < .001) a
139 In multivariate mixed-effects models, the adjusted odds ratio (95% CI) was 0.76 (0.70 to 0.83) for
140 worse 3-month modified Rankin Scale scores; adjusted odds ratios (95% confidence interval) for the s
141 sociated with a raised risk of MS, producing adjusted odds ratios (95% confidence intervals) of 1.22
142 vely associated with allergic sensitisation (adjusted odds ratio [95% CI] per g/dL 0.91 [0.83 to 0.99
143 ith lower odds of moderate or severe stroke (adjusted odds ratio [95% CI], 0.56 [0.51-0.60], 0.65 [0.
144 2], respectively) and in-hospital mortality (adjusted odds ratio [95% CI], 0.75 [0.67-0.85], 0.79 [0.
145 ren had an overall increased risk of eczema (adjusted odds ratio [95% confidence interval]: 1.11 [1.0
146 CI, 0.51-1.22; P = .28) and severe diabetes (adjusted odds ratio, 95% CI, 0.86; 95% CI, 0.54-1.39; P
151 in D concentration (per 10-nmol/L increment: adjusted odds ratio (aOR) = 0.95, 95% confidence interva
152 -associated infant mortality [light smoking: adjusted odds ratio (aOR) = 1.21, 95% confidence interva
153 with mild, whole-pregnancy exposure to cold [adjusted odds ratio (aOR) = 4.75; 95% confidence interva
154 sculopathy (FTV) both with increasing PM2.5 [adjusted odds ratio (aOR) = 5.5; 95% CI: 1.1, 26.8] and
155 among men with peripheral vascular disease (adjusted odds ratio (aOR) = 6.54, 95% confidence interva
156 of receiving ranibizumab declined over time (adjusted odds ratio (aOR) comparing treatment in 2009 vs
157 thout trauma, there was no difference in the adjusted odds ratio (aOR) for 30-day mortality when comp
158 trategy and mortality in the two categories; adjusted odds ratio (aOR) of 0.84 (95% confidence interv
159 s no difference in the odds of death or NDI (adjusted odds ratio (aOR), 0.83; 95% CI, 0.52-1.32), NDI
160 f fever in other trimesters and confounders (adjusted odds ratio (aOR), 1.40; 95% confidence interval
161 he odds of Wave 2 major depressive episodes (adjusted odds ratio (AOR): 1.7; 95% confidence interval:
162 ociation of viruses with CAP was assessed by adjusted odds ratios (aOR) and 95% confidence intervals
163 c regression was used to calculate crude and adjusted odds ratios (AOR) for associations with ASD, an
164 s 42 [49%] of 86 participants, respectively, adjusted odds ratio [aOR] 0.46, 95% CI 0.23-0.89; p=0.02
165 of high-risk HPV than did those not on ART (adjusted odds ratio [aOR] 0.83, 95% CI 0.70-0.99; I(2)=5
166 ncome compared with low-income participants (adjusted odds ratio [aOR] 0.98, 0.97-0.99, p<0.0001), al
167 likelihood of reporting poor or fair health (adjusted odds ratio [aOR] 0.98, 95% CI 0.66-1.44, p=0.91
168 of penicillin or cephalosporin use overall (adjusted odds ratio [aOR] 1.3; 95% CI, 0.8-2.0), we obse
169 disability over the range of the mRS (common adjusted odds ratio [aOR] 1.80, 95% CI 1.09-2.99), and i
170 Health Service increased-risk donor status (adjusted odds ratio [aOR] 2.49, 95% confidence interval
171 ared to those without were as follows: COPD (adjusted odds ratio [aOR] 5.65, 95% CI 5.52-5.79), bronc
173 ing 1 or more chronic conditions themselves (adjusted odds ratio [aOR] = 1.29; 95% confidence interva
174 , and age, this effect remained significant (adjusted odds ratio [aOR] = 1.30, 95% CI 1.09-1.55).
175 ependently associated with renal impairment (adjusted odds ratio [aOR] = 2.1; 95% confidence interval
176 re positively associated with rhinitis ever (adjusted odds ratio [AOR] = 2.95; 95% confidence interva
177 iated with a 3.4-fold increased risk of AMI (adjusted odds ratio [aOR] = 3.41; 95% confidence interva
180 incidence in either the analysis of any use (adjusted odds ratio [aOR] [95% CI]: 1.22 [0.72-2.05]) or
181 children attained minimum dietary diversity (adjusted odds ratio [aOR] for women 1.39, 95% CI 1.03-1.
182 ompared with those discharged within 2 days (adjusted odds ratio [aOR], 0.82; 95% CI, 0.51-1.04; P =
183 clined from 3.1% to 2.6% (P for trend <.001; adjusted odds ratio [aOR], 0.95; 95% CI, 0.94-0.97) driv
185 was associated with increased risk of atopy (adjusted odds ratio [aOR], 1.14; 95% CI, 1.02-1.28 per 1
186 was independently associated with mortality (adjusted odds ratio [aOR], 1.16; 95% CI, 1.08-1.25).
187 pioid use included preoperative tobacco use (adjusted odds ratio [aOR], 1.35; 95% CI, 1.21-1.49), alc
188 52) and greater odds of unfavorable outcome (adjusted odds ratio [aOR], 1.44; 95% CI, 1.24-1.66) comp
189 f arrival increased under the SAED protocol (adjusted odds ratio [AOR], 1.72; 95% confidence interval
190 were higher in children who were overweight (adjusted odds ratio [aOR], 1.7; 95% confidence interval
191 fusion compared with the stage 5D CKD group (adjusted odds ratio [AOR], 1.83; 95% CI, 1.67-2.01; P <
192 ergy, those with resolved or current asthma (adjusted odds ratio [aOR], 1.9 [95% CI, 1.1-1.3] and 1.7
193 n had an increased risk for grooming injury (adjusted odds ratio [AOR], 1.97; 95% CI, 1.28-3.01; P =
194 ere associated both with intensive care use (adjusted odds ratio [aOR], 1.97; P = .01) and longer hos
195 of >/=9 mg/kg compared to doses of <7 mg/kg (adjusted odds ratio [aOR], 10.57; 95% confidence interva
196 ore >/=1 was associated with severe malaria (adjusted odds ratio [aOR], 2.63 [95% confidence interval
197 ated with an unsuccessful treatment outcome (adjusted odds ratio [aOR], 2.69; 95% CI, 0.88 to 8.21),
198 narrow-spectrum penicillins was more likely (adjusted odds ratio [aOR], 2.81, 95% confidence interval
200 and EoE, including prenatal (maternal fever: adjusted odds ratio [aOR], 3.18; 95% CI, 1.27-7.98; pret
201 r PDR relative to those with no retinopathy (adjusted odds ratio [aOR], 3.59; 95% CI, 1.29-10.05; P =
202 iated with recent antecedent antibiotic use (adjusted odds ratio [aOR], 4.17; 95% confidence interval
203 as associated with children <5 years of age (adjusted odds ratio [aOR], 4.7; 95% confidence interval
204 se in the odds of severe (stage 2 or 3) AKI (adjusted odds ratio [aOR], 5.22; 95% CI, 1.35-20.22).
205 ciated with increased risk for preeclampsia (adjusted odds ratio [aOR], 5.9; 95% confidence interval
206 stance is significantly associated with RiC (adjusted odds ratio [aOR], 8.8 [95% confidence interval
207 pital death among patients aged 18-49 years (adjusted odds ratios [aOR] = 0.21; 95% confidence interv
210 ession model was constructed to quantify the adjusted odds ratios (aORs) of the exposure to PM10 and
211 r violence in a greater number of vignettes (adjusted odds ratios [AORs] ranged from 3.87 to 5.74, wi
213 g for age, frailty, and predicted mortality (adjusted odds ratio for 180-day survival, 2.87; 95% CI,
214 ciated with increased in-hospital mortality (adjusted odds ratio for death, 1.03 [95% CI, 1.00-1.05]
215 en than boys before and after puberty onset: adjusted odds ratio for females vs males 0.79 (95%-confi
217 After adjusting for severity of illness, the adjusted odds ratio for hospital mortality was higher in
218 ated by a test-negative design comparing the adjusted odds ratio for influenza test positivity among
220 Compared with more than 120 minutes, the adjusted odds ratio for mortality was 0.76 (CI, 0.64-0.9
221 cross-sectional analyses, the multivariable-adjusted odds ratio for prevalent diabetes comparing hep
222 having 2 or more cesarean deliveries had an adjusted odds ratio for receiving blood transfusion of 1
223 cess and center femoral proportion, the risk-adjusted odds ratio for recent femoral proportion was no
225 and for 63.0% of the children receiving SMC (adjusted odds ratio for success of PPT, 11.7; 95% confid
226 rison with those not on anticoagulation, the adjusted odds ratio for symptomatic intracranial hemorrh
227 worse 3-month modified Rankin Scale scores: adjusted odds ratio for the fifth quintile versus first
228 Cochran-Mantel-Haenszel test); however, the adjusted odds ratio for the highest versus lowest quinti
230 alculated age-standardised estimates and age-adjusted odds ratios for all explanatory factors and sex
236 s who met criteria for two or more outcomes, adjusted odds ratios for the highest quartile of UNGD ac
237 with poor modified Rankin Scale improvement: adjusted odds ratios for the upper two quintiles versus
238 PCV13 against radiological pneumonia was an adjusted odds ratio of 0.57 (0.30-1.08) in children aged
239 but remained statistically significant with adjusted odds ratio of 0.65 (95% CI, 0.49-0.87) for any
241 d rural hospitals in any study year, with an adjusted odds ratio of 1.13 (0.77-1.65) in 2001, 0.99 (0
243 lood vessel status demonstrating the highest adjusted odds ratio of 5.14 (95% CI, 2.20-12.70; P < .00
244 day of CRRT was associated with an increased adjusted odds ratio of death of 1.39 (95% CI, 1.01-1.90;
245 dead (NBD) donors, DCD kidneys had a higher adjusted odds ratio of discard that varied from 1.25 (95
246 usted multivariable analysis showed that the adjusted odds ratio of reoperation for women having 1 pr
247 Compared to encounters with pediatricians, adjusted odds ratio of treatment was 2.02 (95% CI, 1.96-
249 in RSV-infected infants in all cohorts, with adjusted odds ratios of 0.30 (95% confidence interval [C
250 use of IL-2RAb induction was associated with adjusted odds ratios of 0.61 (95% confidence interval [C
251 omen with previous cesarean deliveries, with adjusted odds ratios of 1.16 (95% CI, 0.98-1.37) for 1 c
252 the MLPT group compared with controls, with adjusted odds ratios of 1.8 (95% CI, 1.1-3.0) for cognit
253 y using negative screening as the reference, adjusted odds ratios of IBCs were 3.3 (95% confidence in
254 d with major response in the primary cohort: adjusted odds ratio (OR) 6.3 [95% confidence interval (C
256 ed with an increased risk of bladder cancer [adjusted odds ratios (OR) = 3.90, 95% confidence interva
257 group versus 2.5% in the intervention group (adjusted odds ratio [OR] 0.65, 95% confidence interval [
259 ided patients vs 336 [10%] in 3372 controls; adjusted odds ratio [OR] 0.83 [95% CI 0.70 to 0.99], p=0
260 fibrosis and MUC5B rs35705950 minor alleles (adjusted odds ratio [OR] 1.91, 95% CI 1.02-3.59, p=0.045
261 least one blood pressure-lowering medicine (adjusted odds ratio [OR] 2.23, 95% CI 1.59-3.12); p<0.00
262 ed to ADHD in offspring: multiple sclerosis (adjusted odds ratio [OR] = 1.8; 95% confidence interval
263 nificantly higher odds of patient mortality (adjusted odds ratio [OR] = 5.72; 95% confidence interval
264 points on the NIHSS (83% vs 44%; p = 0.002, adjusted odds ratio [OR] = 6.6, 95% confidence interval
265 associated with equivalent 30-day mortality (adjusted odds ratio [OR], 1.06; 95% confidence interval
266 re likely to die in the hospital than males (adjusted odds ratio [OR], 1.44; 95% CI, 1.12-1.84).
267 associated with higher NAFLD activity score (adjusted odds ratio [OR], 1.644; P = 0.021), whereas ele
268 atment using levator muscle resection (LMR) (adjusted odds ratio [OR], 1.76; P = .04), better preoper
269 ic asthma at study entry were sensitization (adjusted odds ratio [OR], 12; P < .001), eczema (adjuste
270 ly had a record of special educational need (adjusted odds ratio [OR], 8.62; 95% CI, 8.26-9.00), achi
271 rates of degenerative mitral valve disease (adjusted odds ratio [OR]: 1.13 for every additional 10 m
272 the strongest predictor of death at 1 year (adjusted odds ratio [OR]: 3.72; 95% confidence interval
273 800mug FA and any indoor pesticide exposure {adjusted odds ratio [OR]=2.5 [95% confidence interval (C
274 y was greater for nonoverlapping procedures (adjusted odds ratio, OR = 2.14 vs overlapping procedures
275 e survey data were more likely to be female (adjusted odds ratio (ORadj) = 3.1; 95% confidence interv
276 0-43.5]; P=0.02) and prevalence of CAC (68%; adjusted odds ratio [ORadjusted]=3.2; 95% confidence int
277 tic regression analysis was used to estimate adjusted odds ratios (ORs) and 95% confidence intervals
280 mated at implant and patient level to obtain adjusted odds ratios (ORs) and to control possible confo
281 nd low birthweight (J-shaped, p=0.0001); the adjusted odds ratios (ORs) for increasing quartiles of u
284 the presence and severity of ROP (BW and GA adjusted odds ratios [ORs] of 2.46 for any ROP, 2.88 for
285 was inversely associated with incident CVD (adjusted odds ratio per SD increment [OR/SD], 0.69; 95%
286 ssociated with avoidance of starch products (adjusted odds ratio quartile 4 vs quartile 1, 0.73; 95%
287 ceive norepinephrine as initial vasopressor (adjusted odds ratio quartile 4 vs quartile 1, 2.1; 95% C
288 e were more likely to have lactate measured (adjusted odds ratio quartile 4 vs quartile 1, 2.8; 95% C
290 egression to calculate age- and multivariate-adjusted odds ratios to determine the risk of incident A
291 al, 0.51-1.65) and for those on warfarin the adjusted odds ratio was 0.85 (95% confidence interval, 0
292 ual care (475 of 1871 patients [25.4%]); the adjusted odds ratio was 0.97 (95% confidence interval, 0
293 livery was 1.31 (95% CI, 1.03-1.68), and the adjusted odds ratio was 1.35 (95% CI, 0.96-1.91) for wom
294 worse 3-month modified Rankin Scale scores; adjusted odds ratios were 1.45 (1.10-1.90), 1.86 (1.41-2
295 children exposed to ARV drugs through PMTCT; adjusted odds ratios were 1.8 (95% confidence interval [
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。